<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/48-841.02"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/48-841.02/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_48_841_02">
        <akn:num>48-841.02</akn:num>
        <akn:heading>Definitions.</akn:heading>
<akn:subsection eId="subsec_48-841_02_1">
      <akn:num>(1)</akn:num>
      <akn:content><akn:p>“FDA” means the federal Food and Drug Administration.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-841_02_2">
      <akn:num>(2)</akn:num>
      <akn:content><akn:p>“Off-label use” means the use of a prescription drug for human use to treat a condition that is not included in the labeling for that medication, as approved by the federal Food and Drug Administration.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-841_02_3">
      <akn:num>(3)</akn:num>
      <akn:content><akn:p>“Prescriber” means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs for human use in the course of a professional practice.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
